- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Dr. Agarwal's Health Care Limited — PPTs, 29-05-2025: Investor Presentation
1. Financial Highlights:
Dr. Agarwal’s Health Care reported revenue from operations of ₹1,711 Cr in FY2025, up 28.4% YoY from ₹1,332 Cr. EBITDA increased 23.6% to ₹502 Cr with a margin of 28.6%. Adjusted profit after tax rose 22.4% to ₹110 Cr. Cost of goods sold remained stable at 22.1% of sales. Operating expenses grew 28.1%, driven by investments in new centers and talent acquisition. The company is cash-positive with ₹275 Cr in net cash. Facility count rose to 236, serving 2.43 million patients and completing over 282K surgeries, a 28% increase in surgery volume.
2. Strategic Initiatives & Growth Drivers:
Network expanded by 59 centers, including 14 surgical facilities, focusing on Tier 1 and emerging cities. The first tertiary care center was launched in New Delhi to offer full-spectrum services. Growth is fueled by an asset-light, hub-and-spoke model, with targeted capex on greenfield projects, facility upgrades, and technology adoption enhancing scalability.
3. Business Developments:
Acquisitions include Thind Eye Care, supporting entry into Uttar Pradesh, Punjab, and Jammu & Kashmir. New greenfield centers were also launched in India and Africa. The clinical team grew to 831 doctors and 1,849 paramedics, emphasizing quality medical talent to drive excellence.
4. Market Position & Competitive Advantage:
India’s largest eye care chain by facilities and revenue, Dr. Agarwal’s benefits from geographic diversification across 14 states and 9 African countries. Its scalable hub-and-spoke model optimizes resource use and patient access. A mix of mature and emerging centers supports steady growth and profitability.
5. Investor Implications:
Strong expansion and operational leverage highlight positive growth potential, backed by a net cash balance and margin improvement. Investors should watch integration efficiency and margin control as expansion accelerates. Overall, the company projects a sustainable growth path attractive for long-term equity holders.